BE665076A - - Google Patents

Info

Publication number
BE665076A
BE665076A BE665076A BE665076A BE665076A BE 665076 A BE665076 A BE 665076A BE 665076 A BE665076 A BE 665076A BE 665076 A BE665076 A BE 665076A BE 665076 A BE665076 A BE 665076A
Authority
BE
Belgium
Prior art keywords
sep
gelatin
degraded
oxypolygelatin
crosslinked
Prior art date
Application number
BE665076A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE641705A external-priority patent/BE641705A/fr
Application filed filed Critical
Priority to BE665076A priority Critical patent/BE665076A/fr
Publication of BE665076A publication Critical patent/BE665076A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
BE665076A 1963-12-23 1965-06-08 BE665076A (xx)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BE665076A BE665076A (xx) 1963-12-23 1965-06-08

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE641705A BE641705A (xx) 1963-12-23 1963-12-23
BE665076A BE665076A (xx) 1963-12-23 1965-06-08

Publications (1)

Publication Number Publication Date
BE665076A true BE665076A (xx) 1965-12-08

Family

ID=25655617

Family Applications (1)

Application Number Title Priority Date Filing Date
BE665076A BE665076A (xx) 1963-12-23 1965-06-08

Country Status (1)

Country Link
BE (1) BE665076A (xx)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371927A1 (en) * 1976-11-29 1978-06-23 Connaught Lab Anti:poliomyelitis vaccine contg. attenuated viruses - is stabilised by suspending in tris-hydroxy-methyl-amino-methane and L-cystine opt. with acid hydrolysed gelatin
FR2425245A1 (fr) * 1978-05-12 1979-12-07 Sumitomo Chemical Co Procede pour la preparation d'une composition injectable d'urokinase
EP0006671A2 (de) * 1978-07-03 1980-01-09 Firma Dr.Ing. Hans Müller Verfahren zur Erhaltung lebender Mikroorganismen
EP0028563A1 (en) * 1979-10-29 1981-05-13 Merck & Co. Inc. Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371927A1 (en) * 1976-11-29 1978-06-23 Connaught Lab Anti:poliomyelitis vaccine contg. attenuated viruses - is stabilised by suspending in tris-hydroxy-methyl-amino-methane and L-cystine opt. with acid hydrolysed gelatin
FR2425245A1 (fr) * 1978-05-12 1979-12-07 Sumitomo Chemical Co Procede pour la preparation d'une composition injectable d'urokinase
EP0006671A2 (de) * 1978-07-03 1980-01-09 Firma Dr.Ing. Hans Müller Verfahren zur Erhaltung lebender Mikroorganismen
EP0006671A3 (en) * 1978-07-03 1980-02-06 Hans Dr. Ing. Muller Process for the conservation of living microorganisms
EP0028563A1 (en) * 1979-10-29 1981-05-13 Merck & Co. Inc. Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer

Similar Documents

Publication Publication Date Title
EP0841942B1 (fr) Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
FI61807B (fi) Foerfarande foer stabilisering av meningokockpolysackarid
BE1001533A3 (fr) Vaccin vivant attenue stabilise et sa fabrication.
FR2475900A1 (fr) Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0353108B2 (fr) Procédé de stabilisation des vaccins et associations de vaccins à virus atténués conservés sous forme lyophilisée, et compositions obtenues
BE1008163A5 (fr) Nouveaux oligodesoxyribonucleotides a activite anti-ischemique et leur preparation.
EP0013851A1 (fr) Protéoglycanes bactériens purifiés, procédé pour leur préparation et vaccin les contenant
JP2019535668A (ja) 注射デバイスのための医薬ヒドロコルチゾン溶液
BE665076A (xx)
EP0071515B1 (fr) Procédé d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application à la préparation de vaccins
FR2634125A1 (fr) Composition pharmaceutique a base de superoxyde dismutase
JPH0228319B2 (xx)
EP1357895A2 (fr) Composition vaccinale et procede de stabilisation
Gardner et al. Relative stability of pertussis vaccine preserved with merthiolate, benzethonium chloride, or the parabens
EP1981549B1 (fr) Procede d'inactivation virale par chauffage a sec
FR2644064A1 (fr) Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
AU2005203171B2 (en) Botulinum toxin pharmaceutical compositions
CN112245394B (zh) 一种疫苗保护剂
BE896383A (fr) Procede pour stabiliser un facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur
BE641705A (xx)
CH423098A (fr) Procédé de préparation d'un vaccin staphylococcique
BE622212A (xx)
WO1997002044A1 (fr) Conservateur pour composition vaccinale
JP2639668B2 (ja) 制癌剤
FR2522268A1 (fr) Vaccin anti-ourlien vivant et procede pour le stabiliser